
United Spirits Analyst Review May 2026
Updated: 18 May 2026 • 4:47 pm
Posted by:

This United Spirits analyst review for May 2026 covers the key data investors need for UNITDSPR at its current price of Rs 1,287.90. United Spirits (NSE: UNITDSPR) is India’s largest spirits company with a market capitalisation of approximately Rs 36,000 crore, a subsidiary of Diageo PLC (UK), selling whisky, rum, gin, and vodka brands. The analyst consensus target of Rs 1,550 implies meaningful upside, and this United Spirits analyst review examines technical levels, business performance, valuation, and key risks that will determine whether UNITDSPR achieves that target through FY27.
Click Here – Get Free Investment Predictions
United Spirits Company Snapshot May 2026
United Spirits’ premium and above portfolio (McDowell’s Reserve, Black Dog, Johnnie Walker) grows at 18 to 22 percent annually, driving margin expansion. The premiumisation trend in Indian spirits benefits Diageo’s India franchise. The table below summarises the key data referenced in this United Spirits analyst review.
| Parameter | Value |
|---|---|
| NSE Ticker | UNITDSPR |
| Sector | FMCG – Alcoholic Beverages |
| CMP (May 2026) | Rs 1,287.90 |
| 52 Week High | Rs 1,645.00 |
| 52 Week Low | Rs 1,210.80 |
| Market Cap | Rs 36,000 Crore |
| Trailing P/E | 58x |
| Analyst Consensus Target | Rs 1,550 |
| Bull Case Target | Rs 1,900 |
| Bear Case Target | Rs 1,100 |
Analyst Insight in This United Spirits Analyst Review
Senior Research Analyst Ankit Jaiswal flags United Spirits as a stock to watch in May 2026. At Rs 1,287.90, Ankit Jaiswal identifies key support in the Rs 1235 to Rs 1224 band and resistance near Rs 1365. He suggests watching United Spirits for a potential move toward Rs 1,550, subject to FMCG – Alcoholic Beverages sector momentum and Nifty 50 direction. Ankit Jaiswal’s view is one input in this United Spirits analyst review and does not constitute a trade recommendation.
Technical Analysis in This United Spirits Analyst Review
At Rs 1,287.90, UNITDSPR is trading within its 52-week band of Rs 1,210.80 to Rs 1,645.00. The current position relative to the 52-week high and low is the first layer of technical context for any entry or exit decision. Momentum indicators including the 14-day RSI, MACD crossover, and volume trends are useful secondary signals to monitor alongside the Nifty 50 direction.
Near-term support is identified in the Rs 1235 to Rs 1224 band while resistance is seen in the Rs 1365 to Rs 1419 zone. A sustained move above Rs 1365 could open the path toward the analyst consensus target of Rs 1,550.
Screen the best stocks on the Univest Screener.
Key Support and Resistance Levels
- Support Zone: Rs 1235 to Rs 1224 – investors tracking this United Spirits analyst review should watch for stabilisation or a bounce in this range as a potential accumulation signal for UNITDSPR.
- Resistance Zone: Rs 1365 to Rs 1419 – a sustained close above Rs 1365 would be a positive breakout signal worth flagging in this United Spirits analyst review.
- Medium-Term Target: The analyst consensus of Rs 1,550 represents the base-case upside scenario identified in this United Spirits analyst review.
Business Segment Analysis
Premium and Luxury Spirits (Johnnie Walker, Black Dog)
This is the primary revenue and margin driver for United Spirits, directly supporting the earnings trajectory toward the consensus target of Rs 1,550.
Popular Spirits (McDowell’s No.1, Royal Challenge)
This segment adds scale and diversification to United Spirits’s business model and is a meaningful EPS contributor through FY27 and FY28.
On-Trade (Hotels, Bars, Restaurants) Distribution
This represents the medium-term growth frontier for United Spirits and a key re-rating catalyst for the stock over the next 12 to 24 months.
Valuation in This United Spirits Analyst Review
At Rs 1,287.90, United Spirits trades at a trailing P/E of 58x. This United Spirits analyst review presents three valuation scenarios: a bull case of Rs 1,900 on strong earnings delivery and sector tailwinds, a base case of Rs 1,550 at analyst consensus, and a bear case of Rs 1,100 if macro headwinds persist. Q1 FY27 results will be the first key checkpoint for this United Spirits analyst review.
| Scenario | Target Price | Key Condition |
|---|---|---|
| Bull Case | Rs 1,900 | Strong earnings delivery and sector re-rating |
| Base Case (Consensus) | Rs 1,550 | Moderate growth, analyst consensus estimate |
| Bear Case | Rs 1,100 | Earnings miss or macro headwinds |
Trade Outlook for United Spirits
Based on the technical and fundamental analysis in this United Spirits analyst review, investors might watch UNITDSPR near the support zone of Rs 1235 to Rs 1224 for potential opportunities. A flag above Rs 1365 could suggest improving momentum toward Rs 1,550. This article uses watch-and-flag language only and does not constitute a trade recommendation.
Key Risks for United Spirits in FY27
A well-rounded United Spirits analyst review must assess downside risks. Key risks for United Spirits include a macro slowdown affecting FMCG – Alcoholic Beverages sector demand, input cost or regulatory headwinds compressing margins, continued FII selling from Indian equities, and earnings estimate downgrades if Q1 FY27 guidance disappoints. Market conditions may change rapidly. This analysis is not financial advice; investors should perform their own due diligence before investing in UNITDSPR.
Download the Univest iOS App or the Univest Android App to get daily stock recommendations and expert research.
Conclusion: United Spirits Analyst Review Verdict for 2026
This United Spirits analyst review concludes that at Rs 1,287.90, UNITDSPR offers a defined risk-reward with a consensus target of Rs 1,550. The 52-week range of Rs 1,210.80 to Rs 1,645.00 provides context on the current entry point. Use this United Spirits analyst review as a research starting point and consult a SEBI-registered financial advisor before making any investment decisions on UNITDSPR.
Frequently Asked Questions: United Spirits Analyst Review 2026
What is the analyst target for United Spirits in 2026?
The analyst consensus target is Rs 1,550, with a bull case of Rs 1,900 and a bear case of Rs 1,100. Monitor Q1 FY27 earnings for confirmation as highlighted in this United Spirits analyst review.
Is United Spirits a good investment at Rs 1,287.90?
At Rs 1,287.90 with a P/E of 58x and a consensus target of Rs 1,550, this United Spirits analyst review is constructive for medium to long-term investors in the FMCG – Alcoholic Beverages sector. Always consult a SEBI-registered advisor before investing.
What is United Spirits’s 52-week high and low?
The 52-week high is Rs 1,645.00 and the 52-week low is Rs 1,210.80. At Rs 1,287.90, UNITDSPR is positioned within this range as noted in this United Spirits analyst review.
What are the key risks for United Spirits?
Key risks include macro slowdown, input cost pressures, FII selling, and regulatory changes in the FMCG – Alcoholic Beverages sector as assessed in this United Spirits analyst review.
Where can I track live data for United Spirits?
Track United Spirits’s live price and analyst targets on the Univest Screener alongside professional financial advice to complement this United Spirits analyst review.
Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making any investment decisions.
Recent Articles

Proventus Agrocom Q4 FY26 Results: PAT Rs 8 Cr, Revenue Rs 535 Crore
18 May 2026

Mukka Proteins Q4 FY26 Results: PAT Rs 21 Cr, Revenue Rs 381 Crore
18 May 2026

Alembic Pharmaceuticals Q4 FY26 Results: PAT Rs 202 Cr, Revenue Rs 1,848 Crore
18 May 2026

Omaxe Q4 FY26 Results: Loss Rs 191 Cr, Revenue Rs 349 Crore
18 May 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Recent Posts
Proventus Agrocom Q4 FY26 Results: PAT Rs 8 Cr, Revenue Rs 535 Crore
Mukka Proteins Q4 FY26 Results: PAT Rs 21 Cr, Revenue Rs 381 Crore
Alembic Pharmaceuticals Q4 FY26 Results: PAT Rs 202 Cr, Revenue Rs 1,848 Crore
Omaxe Q4 FY26 Results: Loss Rs 191 Cr, Revenue Rs 349 Crore
Reliance Power Analyst Review May 2026
Popular this week
Proventus Agrocom Q4 FY26 Results: PAT Rs 8 Cr, Revenue Rs 535 Crore
Mukka Proteins Q4 FY26 Results: PAT Rs 21 Cr, Revenue Rs 381 Crore
Alembic Pharmaceuticals Q4 FY26 Results: PAT Rs 202 Cr, Revenue Rs 1,848 Crore
Omaxe Q4 FY26 Results: Loss Rs 191 Cr, Revenue Rs 349 Crore
Reliance Power Analyst Review May 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
